Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT por Vincent T. Ho, Haesook T. Kim, Natalie Bavli, Martin Mihm, Olga Pozdnyakova, Matthias Piesche, Heather Daley, Carol Reynolds, Nicholas C. Souders, Corey Cutler, John Koreth, Edwin P. Alyea, Joseph H. Antin, Jerome Ritz, Glenn Dranoff, Robert J. Soiffer

Enlace del recurso